Guinea-Bissau vs Lao People's Democratic Republic: Immunization, Hib3
Guinea-Bissau
68.0%
in 2024
Lao People's Democratic Republic
67.0%
in 2024
Guinea-Bissau rank
171st
Lao People's Democratic Republic rank
174th
Immunization, Hib3 over time
- Guinea-Bissau
- Lao People's Democratic Republic
How they compare
Guinea-Bissau currently reports 68.0% against 67.0% in Lao People's Democratic Republic, a difference of 1.0%.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 171st and Lao People's Democratic Republic ranks 174th of 191 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.5% | 77.6% | 6.9% | Guinea-Bissau |
| 2020s | 71.4% | 67.4% | 4.0% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Guinea-Bissau or Lao People's Democratic Republic?
- Guinea-Bissau, at 68.0% against 67.0% in Lao People's Democratic Republic as of 2024.
- What is the difference in immunization, hib3 between Guinea-Bissau and Lao People's Democratic Republic?
- 1.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Lao People's Democratic Republic?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea-Bissau and Lao People's Democratic Republic rank globally for immunization, hib3?
- Guinea-Bissau ranks 171st and Lao People's Democratic Republic ranks 174th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.